Back to Results

Neuberger Berman High Yield Strategies (NHS)

Neuberger Berman High Yield Strategies (NYSE: NHS) is a closed-end fixed income fund listed on the New York Stock Exchange. Managed by Neuberger Berman Investment Advisers LLC and launched by Neuberger Berman LLC, the fund seeks exposure to global fixed income markets, with a focus on high yield debt securities across a range of industries. The portfolio scope described in the source includes sectors such as auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom services, gaming, and gas distribution. Formerly known as Neuberger High Yield Strategies Fund, the fund was formed on July 28, 2003 and is domiciled in the United States.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Payment Date Dividend Yield Market Cap Payout Ratio
NYSE-NHS
Not available
Not available
Not available
Fair
September 30, 2026
19.3%
174.8 M
160.3%
Valuation • Fair Value

Neuberger Berman High Yield Strategies (NYSE-NHS) Fair Value by Valuation Model

No usable valuation estimate is currently available for Neuberger Berman High Yield Strategies (NYSE-NHS); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Neuberger Berman High Yield Strategies (NYSE-NHS). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Neuberger Berman High Yield Strategies (NYSE-NHS)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

23.614 M

Current operating scale indicator.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Neuberger Berman High Yield Strategies (NYSE-NHS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Neuberger Berman High Yield Strategies (NYSE-NHS)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Neuberger Berman High Yield Strategies (NYSE-NHS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Neuberger Berman High Yield Strategies (NYSE-NHS)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Dividend Payment Date

September 30, 2026

Dividend Yield

19.3%

Current income yield reference.

Payout Ratio

160.3%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Neuberger Berman High Yield Strategies (NYSE-NHS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Neuberger Berman High Yield Strategies (NYSE-NHS) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Neuberger Berman High Yield Strategies (NYSE-NHS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Neuberger Berman High Yield Strategies (NYSE-NHS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Neuberger Berman High Yield Strategies (NYSE-NHS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Neuberger Berman High Yield Strategies (NYSE-NHS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Neuberger Berman High Yield Strategies (NYSE-NHS) Stock FAQ

Data-supported answers about Neuberger Berman High Yield Strategies (NYSE-NHS), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Fair
Current financial-health read

A reliable fair value estimate is not currently available for Neuberger Berman High Yield Strategies (NYSE-NHS). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Neuberger Berman High Yield Strategies (NYSE-NHS) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 19.3%, payment date is September 30, 2026.

The current market capitalization listed for Neuberger Berman High Yield Strategies is 174.8 M.

The ticker symbol for Neuberger Berman High Yield Strategies is NYSE-NHS, and the stock is listed on NYSE.

Neuberger Berman High Yield Strategies (NYSE-NHS) is listed on NYSE.

Similar Capital Markets Stocks View more on NYSE

Comparable companies from the same industry, limited to one security per issuer.

MS NYSE Morgan Stanley Fair Value Fair Market Cap 314.4 B
MS_PA NYSE Morgan Stanley Pa ADR Fair Value Undervalued Market Cap 314.4 B
MS_PE NYSE Morgan Stanley Pe ADR Fair Value Undervalued Market Cap 314.4 B
MS_PF NYSE Morgan Stanley Pf ADR Fair Value Undervalued Market Cap 314.4 B
MS_PI NYSE Morgan Stanley Pi ADR Fair Value Undervalued Market Cap 314.4 B
GS NYSE Goldman Sachs Group Inc Fair Value Fair Market Cap 287.5 B
BLK NYSE BlackRock Inc Fair Value Fair Market Cap 173.5 B
SCHW NYSE Charles Schwab Corp Fair Value Undervalued Market Cap 173.5 B
IBKR NASDAQ Interactive Brokers Group Inc Fair Value Fair Market Cap 158 B
BX NYSE Blackstone Inc Fair Value Undervalued Market Cap 155.3 B
UBS NYSE UBS Group AG Fair Value Fair Market Cap 150.5 B
SPGI NYSE S&P Global Inc Fair Value Fair Market Cap 118.6 B
HOOD NASDAQ Robinhood Markets Inc Fair Value Overvalued Market Cap 111.7 B
BNY NYSE Bank of New York Mellon Corp Fair Value Fair Market Cap 101.9 B
CME NASDAQ CME Group Inc Fair Value Fair Market Cap 96.083 B
KKR NYSE KKR & Co LP Fair Value Fair Market Cap 88.363 B
ICE NYSE Intercontinental Exchange Inc Fair Value Fair Market Cap 85.854 B
BN NYSE Brookfield Corp Fair Value Fair Market Cap 84.512 B
MCO NYSE Moodys Corporation Fair Value Fair Market Cap 81.265 B
BAM NYSE Brookfield Asset Management Inc Fair Value Fair Market Cap 73.573 B